FolioLanternBeta
BBIOBridgeBio Pharma, Inc.

Charles Homcy

Director at BridgeBio Pharma, Inc., as of Jun 24, 2026No sales or purchases in the past 12 months.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
920K
shares held after the latest filing, BridgeBio Pharma, Inc.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
2
companies filed for

Last filing: Jun 24, 2026. Most recent sale before this period: Aug 11, 2025.

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
BridgeBio Pharma, Inc. (BBIO)DirectorJun 27, 2019Jun 24, 2026
Cytokinetics Inc (CYTK)Former DirectorApr 28, 2004May 27, 2008

Also a director at

Cytokinetics Inc (CYTK) (no filing in the last 18 months)

Recent filings

The last 2 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.